Healthcare Triangle, Inc. (HCTI)
NASDAQ: HCTI · Real-Time Price · USD
0.7457
+0.0022 (0.30%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Healthcare Triangle Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 25.67 | 13.89 | 11.7 | 33.2 | 45.89 | 35.27 | |
Revenue Growth | 116.37% | 18.77% | -64.77% | -27.64% | 30.10% | 12.54% |
Cost of Revenue | 20.15 | 12 | 8.81 | 26.43 | 34.59 | 24.75 |
Gross Profit | 5.53 | 1.89 | 2.89 | 6.78 | 11.3 | 10.52 |
Selling, General & Admin | 17.59 | 10.42 | 6.15 | 10.4 | 12.17 | 9.2 |
Research & Development | 0.47 | 0.54 | 0.43 | 0.8 | 8.14 | 5.26 |
Operating Expenses | 20.25 | 11.68 | 7.64 | 12.76 | 23.25 | 15.88 |
Operating Income | -14.73 | -9.79 | -4.75 | -5.99 | -11.96 | -5.36 |
Interest Expense | -0.31 | -0.57 | -1.21 | -0.97 | -0.21 | -0.57 |
Currency Exchange Gain (Loss) | -0.1 | -0.02 | - | - | - | - |
Other Non Operating Income (Expenses) | -1.91 | 0.86 | 0.01 | 0.01 | - | - |
EBT Excluding Unusual Items | -17.04 | -9.52 | -5.96 | -6.94 | -12.17 | -5.93 |
Asset Writedown | 0.04 | 0.04 | - | -1.71 | -4.37 | - |
Other Unusual Items | - | - | - | - | 2.68 | - |
Pretax Income | -17 | -9.48 | -5.96 | -8.65 | -13.85 | -5.93 |
Income Tax Expense | 0.02 | - | 0.01 | 0.04 | 0.51 | 0.02 |
Net Income | -17.02 | -9.48 | -5.97 | -8.69 | -14.36 | -5.95 |
Net Income to Common | -17.02 | -9.48 | -5.97 | -8.69 | -14.36 | -5.95 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1 | 0 | - | - | - | - |
Shares Outstanding (Diluted) | 1 | 0 | - | - | - | - |
Shares Change | 7691.61% | - | - | - | - | - |
EPS (Basic) | -21.48 | -153.15 | - | - | - | - |
EPS (Diluted) | -21.48 | -153.15 | - | - | - | - |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -15.48 | -16.53 | -1.08 | -2.16 | -5.39 | -7.19 |
Free Cash Flow Per Share | -19.53 | -267.14 | - | - | - | - |
Gross Margin | 21.52% | 13.61% | 24.71% | 20.41% | 24.62% | 29.83% |
Operating Margin | -57.37% | -70.47% | -40.62% | -18.02% | -26.06% | -15.19% |
Profit Margin | -66.30% | -68.22% | -51.03% | -26.16% | -31.29% | -16.87% |
Free Cash Flow Margin | -60.30% | -118.99% | -9.24% | -6.51% | -11.75% | -20.39% |
EBITDA | -13.09 | -9.08 | -3.86 | -4.42 | -9.02 | -3.94 |
EBITDA Margin | -51.00% | -65.40% | -33.02% | -13.31% | -19.65% | -11.16% |
D&A For EBITDA | 1.63 | 0.71 | 0.89 | 1.57 | 2.94 | 1.42 |
EBIT | -14.73 | -9.79 | -4.75 | -5.99 | -11.96 | -5.36 |
EBIT Margin | -57.37% | -70.47% | -40.62% | -18.02% | -26.06% | -15.19% |
Advertising Expenses | - | 1.7 | 0.61 | - | - | - |